Evolent Health, Inc (EVH) Financials
EVH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 2.6 billion | 1.6 billion |
2023-12-31 | 2.7 billion | 1.6 billion |
2023-09-30 | 2.7 billion | 1.6 billion |
2023-06-30 | 2.6 billion | 1.6 billion |
EVH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -438000 | 18.8 million |
2023-12-31 | 83.3 million | 10.6 million |
2023-09-30 | 53.7 million | 10.2 million |
2023-06-30 | -6.2 million | 9.0 million |
EVH Net Income
No data available :(
EVH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 216.7 million | - | 45.2 million |
2023-12-31 | 192.8 million | - | 47.7 million |
2023-09-30 | 184.5 million | 599.9 million | 52.6 million |
2023-06-30 | 142.5 million | 633.0 million | 62.8 million |
EVH Shares Outstanding
EVH Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 5.3 million | - | 79.1 million | -10.3 million |
2023-12-31 | 6.1 million | 6.6 million | 180.1 million | 35.0 billion |
2023-09-30 | 6.8 million | 6.6 million | 80.8 million | - |
2023-06-30 | 6.8 million | 6.8 million | 90.4 million | - |
EVH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 639.7 million | 565.1 million |
2023-12-31 | 556.1 million | 454.4 million |
2023-09-30 | 511.0 million | 386.6 million |
2023-06-30 | 469.1 million | 351.9 million |
EVH
Price: $23.28
52 week price:
Earnings Per Share: -1.26 USD
P/E Ratio: -29.50
Exchange: NYQ
Sector: Healthcare
Industry: Health Information Services
Volume: 198391
Ebitda: -6.2 millionMarket Capitalization: 2.7 billion